Navigation Links
Boston Scientific Announces Results for Third Quarter Ended September 30, 2009
Date:10/19/2009

intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item IA- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

Use of non-GAAP Financial Information

A reconciliation of the Company's non-GAAP financial measures to the corresponding GAAP measures, and an explanation of the Company's use of these non-GAAP measures, is included in the exhibits attached to this press release.

    CONTACT:

    Paul Donovan
    508-650-8541 (office)
    508-667-5165 (mobile)
    Media Relations
    Boston Scientific Corporation

    Larry Neumann
    508-650-8696 (office)
    Investor Relations
    Boston Scientific Corporation

                                BOSTON SCIENTIFIC CORPORATION
                      CONDENSED CONSOLIDATED GAAP RESULTS OF OPERATIONS
                                         (Unaudited)

                             Three Months Ended             Nine Months Ended
                                September 30,                 September 30,
          
'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
2. Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents
3. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
4. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
5. The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA -- Hynes Convention Center October 31 -- November 3, 2009
6. SPIRIT IV Results Reaffirm Strong Performance of Boston Scientific PROMUS(R) and TAXUS(R) Express(R) Stents
7. Boston Scientific Announces Schedule for European Society of Cardiology Congress
8. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
9. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
10. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
11. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... and 300mg oral tablets, indicated for use in the ... Propafenone Hydrochloride 150mg, 225mg and 300mg tablets was $14 ... Arthur S. Przybyl , President and Chief Executive Officer ... our fourth product from the portfolio of approved generic ...
(Date:3/31/2015)... March 31, 2015  Oxis International, Inc. (OXIS) (OXI.PA) ... and commercialization, announced today Oxis CEO Tony Cataldo ... Oxis common shares on the Euronext exchange. Oxis shares ... symbol OXIS.   Oxis Chairman and CEO ... move forward with its strategies launched in 2014 and ...
(Date:3/31/2015)... DUBLIN , Mar. 27, 2015 Research ... announced the addition of the "North American ... Laboratory Information System), by Type (Clinical Pathology Laboratory ... Forecast to 2019" report to their offering. ... market is estimated to grow at a CAGR ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Oxis International Inc. Announces Request for Euronext Trading Suspension 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 3
... of Senior Notes in Connection with... -- ARDEE, Ireland, Sept. 24 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... MSON ), a developer of state of ... used for acute health conditions, today announced plans to ... financial results on Tuesday, September 28, 2010.  Michael A. ... Senior VP and Chief Financial Officer, will host a ...
Cached Medicine Technology:Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 2Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 3Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 4Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 5Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 6Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 7Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 8Misonix Schedules Fourth Quarter and Fiscal 2010 Financial Results Conference Call; September 28, 2010 at 4:30 p.m. Eastern 2
(Date:4/1/2015)... April 01, 2015 Enterprise Integration ... Global Edition, a distinguished list and report identifying ... The complete 501 list is currently available on ...     The top ranked MSPs in North America , ... and Africa ,     The top MSPs in ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 On November 24, ... All-Pro Lawrence Taylor to discuss the problem of substance abuse ... his own history of drug abuse and recovery, gives a ... Nicknamed “L.T.” by his teammates on the New York Giants, ... due to failed drug tests, yet he was able to ...
(Date:3/31/2015)... Dr. Parsa Mohebi, founder of Parsa Mohebi Hair Restoration has ... of using beard hair to fill in balding areas ... has now become an absolute option for giving patients the best ... believe that beard to scalp hair transplant can be a patients ... as dense as we would like it,” says Dr. Parsa Mohebi. ...
(Date:3/31/2015)... 2015 Karen A. Daley, Ph.D. will ... Rivier University’s Commencement ceremony on May 9, 2015 ... in recognition of her eminent career as a nurse, ... front-line caregiver and senior staff nurse at Brigham and ... to leadership roles, including President of the American Nurses ...
(Date:3/31/2015)... 31, 2015 Medical DNA Labs, LLC, ... all criteria for Laboratory Accreditation by COLA, a national ... laboratories that apply rigid standards of quality in day-to-day ... testing, and pass a rigorous on-site laboratory survey. ... a result of a long-term commitment to provide quality ...
Breaking Medicine News(10 mins):Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 2Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 3Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Is Beard to Scalp Hair Transplant the Future? 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2
... the International Journal of Andrology reveals that semen ... Finland, a country that previously was a region with high ... cancer in the Finnish population showed a remarkable increase, following ... the Americas. , Led by Jorma Toppari, MD, PhD, of ...
... infants of HIV-infected mothers a daily dose of the ... of HIV transmission to the infants at age 6 ... six weeks, according to preliminary clinical trial data presented ... percent reduction in HIV transmission risk through breast milk ...
... HealthDay Reporter , WEDNESDAY, March 2 (HealthDay News) -- ... investigators have determined that there are no real differences in ... at a time or continuously. Nor was there ... higher dose, although there was a trend toward improvement the ...
... leading preventable cause of death and disease in the U.S., ... or its consequences. And yet teens still smoke. Indeed, smoking ... of adult smokers became hooked by the time they were ... do. While studies have linked cigarette smoking ...
... time of HIV treatment initiation significantly reduces poor adherence ... a recent study in PLoS Medicine by ... University of Washington, who works at the Coptic Hope ... study published March 1 also found that using an ...
... News) -- Epilepsy patients who are poor are more ... a lower overall quality of life compared to those ... patients also visit hospital emergency departments more often and ... lead author Dr. Charles E. Begley, professor of management ...
Cached Medicine News:Health News:6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds 2Health News:6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds 3Health News:Heart Failure Patients Don't Need Continuous Infusion of Diuretics: Study 2Health News:Heart Failure Patients Don't Need Continuous Infusion of Diuretics: Study 3Health News:Tobacco smoking impacts teens' brains, UCLA study shows 2Health News:Tobacco smoking impacts teens' brains, UCLA study shows 3Health News:Study in PLoS: Intensive adherence counseling to HIV treatment improves patient outcomes 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: